Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- From thinning to thriving? New hair loss treatment is showing promising results in trials
- Surprising coffee link: Daily cups may slow ageing in severe mental illness
- Malaria crisis looms as WHO reveals explosive rise in drug resistance
- Study shows nanoplastics from bottles are not just pollution—They may be harming you from within
- Are birth control pills affecting your mental health? New study raises red flags
-1763561110.jpg "Image of the day: November 19, 2025")
